Stoke Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Good afternoon, everyone. Thank you for joining us at the UBS Virtual Healthcare Conference day one. I'm excited to have the Stoke Therapeutics management team here with us for a fireside chat. And I'm joined by Ed Kaye, CEO of Stoke. Ed, welcome, and thank you for making time for us today.
Well, thank you. It's a pleasure to be here, and I look forward to talking about some of our programs.
Great. So perhaps we can start off with a big picture question here as Stoke is positioned to initiate several trials in the US and EU for the lead program, and you also identified another target from the TANGO platform. So what is the vision here as you continue to make clinical progress across the platform and add to the pipeline?
So, yes, our expectation and what we're building out is really a full-service
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
